Publications by authors named "Mike Hafey"

Claim this Profile
A
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors.
Thomas J Tucker, Mark W Embrey, Candice Alleyne, Rupesh P Amin, Alan Bass, Mike Hafey

J Med Chem· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raltegravir has a low propensity to cause clinical drug interactions through inhibition of major drug transporters: an in vitro evaluation.
Matthew L Rizk, Robert Houle, Grace Hoyee Chan, Mike Hafey, Elizabeth G Rhee

Antimicrob Agents Chemother· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Madin-Darby canine kidney II cells: a pharmacologically validated system for NPC1L1-mediated cholesterol uptake.
Adam B Weinglass, Martin G Köhler, Emmanuel O Nketiah, Jessica Liu, William Schmalhofer, Mike Hafey

Mol Pharmacol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis